Business Context and Reporting Period
This Form 8-K Current Report was filed by TopSpin Medical, Inc. on September 20, 2010. The registrant is incorporated in Delaware and maintains its principal executive offices in Tel Aviv, Israel. The report addresses a change in the company's financial leadership effective September 26, 2010.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The only financial data disclosed relates to the compensation for a new service agreement:
- Consulting Fee: 13,000 NIS per month (approximately $3,540 USD), plus value-added tax.
- Contract Term: One year, terminable by either party with 60 days' prior written notice.
Material Changes
The primary material change reported is the departure of Shiri Blackman, who served as the Company's controller and acting Chief Financial Officer. Her employment terminates effective September 26, 2010. Concurrently, the Company entered into an agreement with Uri Ben-Or and CFO Direct Ltd. to provide Chief Financial Officer services.
Management Commentary and Risks
Management has engaged Uri Ben-Or, a Certified Public Accountant with an MBA from Bar Ilan University, to assume CFO duties. Mr. Ben-Or has previously served as CEO of CFO Direct Ltd. since 2007 and as Vice President of Finance at Glycominds Ltd. from 2001 to 2005. The filing notes that the agreement contains customary confidentiality provisions. No specific risks, contingencies, or unusual items beyond the leadership transition are detailed in this report.
Investor Verification Checklist
- Verify the exact termination date of Shiri Blackman (September 26, 2010).
- Confirm the total annual cost of the new CFO arrangement including VAT.
- Review the full text of the agreement filed as Exhibit 10.1 in the subsequent Form 10-Q for the quarter ended September 30, 2010.
- Assess the impact of the CFO transition on the company's upcoming financial reporting cycle.